The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--clinical overview of gastroesophageal reflux disease. Roundtable discussion.

J. Danzig, R. Navarro, D. Inami, A. Morreale, Aaron Zev Tokayer, W. Wong, J. Compton, R. N. Page, F. B. Sweet

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The importance of gastroesophageal reflux disease (GERD) to managed health care systems cannot be overestimated. It contributes significantly to the use of health care resources, including doctor's services, medication consumption, and diagnostic testing. A roundtable meeting of 13 managed care experts was convened January 23, 2001 in Dallas, to discuss the implications of GERD on the managed care system. The following proceedings are published in five sections. In the first part, Jeffrey Danzig, MD, a gastroenterologist, provides the clinical foundation for the discussion, based on the existing literature and his personal practice.

Original languageEnglish (US)
Title of host publicationManaged care interface
Pages13-20
Number of pages8
VolumeSuppl B
StatePublished - 2001
Externally publishedYes

Fingerprint

Proton Pump Inhibitors
Managed Care Programs
Gastroesophageal Reflux
Delivery of Health Care
Health Resources
Therapeutics

ASJC Scopus subject areas

  • Health Policy

Cite this

The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--clinical overview of gastroesophageal reflux disease. Roundtable discussion. / Danzig, J.; Navarro, R.; Inami, D.; Morreale, A.; Tokayer, Aaron Zev; Wong, W.; Compton, J.; Page, R. N.; Sweet, F. B.

Managed care interface. Vol. Suppl B 2001. p. 13-20.

Research output: Chapter in Book/Report/Conference proceedingChapter

Danzig, J, Navarro, R, Inami, D, Morreale, A, Tokayer, AZ, Wong, W, Compton, J, Page, RN & Sweet, FB 2001, The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--clinical overview of gastroesophageal reflux disease. Roundtable discussion. in Managed care interface. vol. Suppl B, pp. 13-20.
Danzig, J. ; Navarro, R. ; Inami, D. ; Morreale, A. ; Tokayer, Aaron Zev ; Wong, W. ; Compton, J. ; Page, R. N. ; Sweet, F. B. / The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--clinical overview of gastroesophageal reflux disease. Roundtable discussion. Managed care interface. Vol. Suppl B 2001. pp. 13-20
@inbook{9ad02286909b4a3fa3ffb5fd828dbaf3,
title = "The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--clinical overview of gastroesophageal reflux disease. Roundtable discussion.",
abstract = "The importance of gastroesophageal reflux disease (GERD) to managed health care systems cannot be overestimated. It contributes significantly to the use of health care resources, including doctor's services, medication consumption, and diagnostic testing. A roundtable meeting of 13 managed care experts was convened January 23, 2001 in Dallas, to discuss the implications of GERD on the managed care system. The following proceedings are published in five sections. In the first part, Jeffrey Danzig, MD, a gastroenterologist, provides the clinical foundation for the discussion, based on the existing literature and his personal practice.",
author = "J. Danzig and R. Navarro and D. Inami and A. Morreale and Tokayer, {Aaron Zev} and W. Wong and J. Compton and Page, {R. N.} and Sweet, {F. B.}",
year = "2001",
language = "English (US)",
volume = "Suppl B",
pages = "13--20",
booktitle = "Managed care interface",

}

TY - CHAP

T1 - The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--clinical overview of gastroesophageal reflux disease. Roundtable discussion.

AU - Danzig, J.

AU - Navarro, R.

AU - Inami, D.

AU - Morreale, A.

AU - Tokayer, Aaron Zev

AU - Wong, W.

AU - Compton, J.

AU - Page, R. N.

AU - Sweet, F. B.

PY - 2001

Y1 - 2001

N2 - The importance of gastroesophageal reflux disease (GERD) to managed health care systems cannot be overestimated. It contributes significantly to the use of health care resources, including doctor's services, medication consumption, and diagnostic testing. A roundtable meeting of 13 managed care experts was convened January 23, 2001 in Dallas, to discuss the implications of GERD on the managed care system. The following proceedings are published in five sections. In the first part, Jeffrey Danzig, MD, a gastroenterologist, provides the clinical foundation for the discussion, based on the existing literature and his personal practice.

AB - The importance of gastroesophageal reflux disease (GERD) to managed health care systems cannot be overestimated. It contributes significantly to the use of health care resources, including doctor's services, medication consumption, and diagnostic testing. A roundtable meeting of 13 managed care experts was convened January 23, 2001 in Dallas, to discuss the implications of GERD on the managed care system. The following proceedings are published in five sections. In the first part, Jeffrey Danzig, MD, a gastroenterologist, provides the clinical foundation for the discussion, based on the existing literature and his personal practice.

UR - http://www.scopus.com/inward/record.url?scp=0035231429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035231429&partnerID=8YFLogxK

M3 - Chapter

VL - Suppl B

SP - 13

EP - 20

BT - Managed care interface

ER -